Tasmanian Botanics
Cultivation & AU-GMP Manufacturing
ABN 27 845 110 293
Brighton, TAS 7030
(03) 6212 4400 · enquiries@tasmanianbotanics.com.au
Certificate of Analysis
B26-0407. Pending
Product
Tassie Midlands · Bulk. Released
Item code
-
Lot number
B26-0407
Cultivar
Tassie Midlands
Genetics
In-house Tasmanian selection
Batch size
101.5 kg
Manufacturing run
MB-26-0400
Source harvest
HB-26-107
Crop batch
CB-26-0288
Date of manufacture
8 Jul 2026
Expiry
8 Jul 2028
Testing laboratory
Not yet sampled
| Analyte | Method | Specification | Result | Outcome |
|---|---|---|---|---|
| Total THC | HPLC-DAD | 19% ± 20% | Pending | Pending |
| Total CBD | HPLC-DAD | Reported | Pending | Pending |
| Water activity | AOAC 978.18 | ≤ 0.65 aᵥ | Pending | Pending |
| Total yeast & mould | TGO 93 · plate count | ≤ 1.0 × 10⁵ CFU/g | Pending | Pending |
| E. coli | TGO 93 | Absent / g | Absent | Fail |
| Salmonella spp. | TGO 93 | Absent / 10 g | Absent | Fail |
| Heavy metals (As, Cd, Pb, Hg) | ICP-MS | TGO 93 limits | Pending | Pending |
| Pesticides (400-analyte panel) | LC-MS/MS · GC-MS/MS | TGO 93 limits | Pending | Pending |
| Foreign matter | Visual | ≤ 2% w/w | Pending | Pending |
Disposition
Released
Testing in progress. The lot remains in quarantine and cannot be picked until release.
Certified by
Fiona Ballard
Quality Manager & Authorised Person
Awaiting laboratory report
Signature
Issued under TGA manufacturing licence MI-2024-LI-02318-1 and ODC manufacture licence ML-0112. Tested against Therapeutic Goods Order No. 93, the Standard for Medicinal Cannabis. Generated by the Tasmanian Botanics operations platform on 28 Jul 2026.